BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 18461142)

  • 21. Association of CC-chemokine ligand-2 gene polymorphisms with leprosy reactions.
    Biswas SK; Mohanty KK; Singh V; Natrajan M; Arora M; Chakma JK; Tripathy SP
    Microbes Infect; 2024; 26(4):105298. PubMed ID: 38244764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of a Toll-like receptor 1 polymorphism with heightened Th1 inflammatory responses and antibiotic-refractory Lyme arthritis.
    Strle K; Shin JJ; Glickstein LJ; Steere AC
    Arthritis Rheum; 2012 May; 64(5):1497-507. PubMed ID: 22246581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The polymorphism P315L of human toll-like receptor 1 impairs innate immune sensing of microbial cell wall components.
    Omueti KO; Mazur DJ; Thompson KS; Lyle EA; Tapping RI
    J Immunol; 2007 May; 178(10):6387-94. PubMed ID: 17475868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TLR-9 Plays a Role in
    Dias AA; Silva CAME; da Silva CO; Linhares NRC; Santos JPS; Vivarini AC; Marques MÂM; Rosa PS; Lopes UG; Berrêdo-Pinho M; Pessolani MCV
    Front Immunol; 2021; 12():657449. PubMed ID: 34456901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential trafficking of TLR1 I602S underlies host protection against pathogenic mycobacteria.
    Hart BE; Tapping RI
    J Immunol; 2012 Dec; 189(11):5347-55. PubMed ID: 23105135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations between HLA-DRB1 alleles and leprosy in an Indonesian population.
    Soebono H; Giphart MJ; Schreuder GM; Klatser PR; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):190-6. PubMed ID: 9251590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation and regulation of Toll-like receptors 2 and 1 in human leprosy.
    Krutzik SR; Ochoa MT; Sieling PA; Uematsu S; Ng YW; Legaspi A; Liu PT; Cole ST; Godowski PJ; Maeda Y; Sarno EN; Norgard MV; Brennan PJ; Akira S; Rea TH; Modlin RL
    Nat Med; 2003 May; 9(5):525-32. PubMed ID: 12692544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic polymorphisms of toll-like receptors in leprosy patients from southern Brazil.
    Masin PS; Visentin HA; Elpidio LNS; Sell AM; Visentainer L; Lima Neto QA; Zacarias JMV; Couceiro P; Higa Shinzato A; Santos Rosa M; Rodrigues-Santos P; Visentainer JEL
    Front Genet; 2022; 13():952219. PubMed ID: 36313452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic, epidemiological and biological analysis of interleukin-10 promoter single-nucleotide polymorphisms suggests a definitive role for -819C/T in leprosy susceptibility.
    Pereira AC; Brito-de-Souza VN; Cardoso CC; Dias-Baptista IM; Parelli FP; Venturini J; Villani-Moreno FR; Pacheco AG; Moraes MO
    Genes Immun; 2009 Mar; 10(2):174-80. PubMed ID: 19110537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LRRK2 and RIPK2 variants in the NOD 2-mediated signaling pathway are associated with susceptibility to Mycobacterium leprae in Indian populations.
    Marcinek P; Jha AN; Shinde V; Sundaramoorthy A; Rajkumar R; Suryadevara NC; Neela SK; van Tong H; Balachander V; Valluri VL; Thangaraj K; Velavan TP
    PLoS One; 2013; 8(8):e73103. PubMed ID: 24015287
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TLR1, TLR2, and TLR6 gene polymorphisms are associated with increased susceptibility to complicated skin and skin structure infections.
    Stappers MH; Thys Y; Oosting M; Plantinga TS; Ioana M; Reimnitz P; Mouton JW; Netea MG; Joosten LA; Gyssens IC
    J Infect Dis; 2014 Jul; 210(2):311-8. PubMed ID: 24511099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Signaling lymphocytic activation molecule expression and regulation in human intracellular infection correlate with Th1 cytokine patterns.
    García VE; Quiroga MF; Ochoa MT; Ochoa L; Pasquinelli V; Fainboim L; Olivares LM; Valdez R; Sordelli DO; Aversa G; Modlin RL; Sieling PA
    J Immunol; 2001 Nov; 167(10):5719-24. PubMed ID: 11698444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autophagy gene polymorphism is associated with susceptibility to leprosy by affecting inflammatory cytokines.
    Yang D; Chen J; Shi C; Jing Z; Song N
    Inflammation; 2014 Apr; 37(2):593-8. PubMed ID: 24264476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in cellular response to mycobacterial antigens and cytokine production patterns in leprosy patients during multiple drug therapy.
    Trao VT; Huong PL; Thuan AT; Anh DD; Trach DD; Rook GA; Wright EP
    Immunology; 1998 Jun; 94(2):197-206. PubMed ID: 9741341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TLR1 Variant H305L Associated with Protection from Pulmonary Tuberculosis.
    Meyer CG; Reiling N; Ehmen C; Ruge G; Owusu-Dabo E; Horstmann RD; Thye T
    PLoS One; 2016; 11(5):e0156046. PubMed ID: 27214039
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of a whole blood assay to monitor the immune response to mycobacterial antigens in leprosy patients: a predictor for type 1 reaction onset?
    Weir RE; Butlin CR; Neupane KD; Failbus SS; Dockrell HM
    Lepr Rev; 1998 Sep; 69(3):279-93. PubMed ID: 9805883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential immunoglobulin and complement levels in leprosy prior to development of reversal reaction and erythema nodosum leprosum.
    Amorim FM; Nobre ML; Nascimento LS; Miranda AM; Monteiro GRG; Freire-Neto FP; Queiroz MDCP; Queiroz JW; Duthie MS; Costa MR; Reed SG; Johnson WD; Dupnik KM; Jeronimo SMB
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007089. PubMed ID: 30689631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A frequent Toll-like receptor 1 gene polymorphism affects NK- and T-cell IFN-γ production and is associated with Helicobacter pylori-induced gastric disease.
    Yang CA; Scheibenbogen C; Bauer S; Kleinle C; Wex T; Bornschein J; Malfertheiner P; Hellmig S; Schumann RR; Hamann L
    Helicobacter; 2013 Feb; 18(1):13-21. PubMed ID: 23067142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Learning from leprosy: insight into the human innate immune response.
    Montoya D; Modlin RL
    Adv Immunol; 2010; 105():1-24. PubMed ID: 20510728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.